opeartes as a tech-forward, diversified, multi-jurisdictional high-growth entity capitalizing on emerging opportunities across real estate development, digital asset innovation and reproductive health solutions. The company is headquartered in Bangkok, Bangkok Metropolis and currently employs 87 full-time employees. The company went IPO on 2022-02-15. The firm operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia.
最新の財務諸表(Form-10K)によると、NewGenIvf Group Ltdの総資産は$0で、純損失は$0です。
NIVFの主要な財務比率は何ですか?
NewGenIvf Group Ltdの流動比率は0、純利益率は0、1株当たり売上高は$0です。
NewGenIvf Group Ltdの収益はセグメントまたは地域別にどのように分けられていますか?
NewGenIvf Group Ltd の最大収益セグメントは In Vitro Fertilization Treatment Service で、最新の利益発表における収益は 3,905,863 です。地域別に見ると、Kyrgyzstan が NewGenIvf Group Ltd の主要市場であり、収益は 2,312,348 です。